| Identification | Back Directory | [Name]
5-TRANS PROSTAGLANDIN F2ALPHA | [CAS]
36150-01-3 | [Synonyms]
5,6-trans-PGF2α)
5-trans Prostaglandin F2α
PXGPLTODNUVGFL-UAAPODJFSA-N
5-TRANS PROSTAGLANDIN F2ALPHA
Dinoprost trometamol EP Impurity A
9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-5E,13E-DIEN-1-OIC ACID
(E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic Acid
(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid ((5E)-PGF2α | [Molecular Formula]
C20H34O5 | [MDL Number]
MFCD00135233 | [MOL File]
36150-01-3.mol | [Molecular Weight]
354.48 |
| Chemical Properties | Back Directory | [Boiling point ]
531.0±50.0 °C(Predicted) | [density ]
1.153±0.06 g/cm3(Predicted) | [solubility ]
10 mM Na2CO3: >6.5 mg/ml; DMF: >100 mg/ml; DMSO: >100 mg/ml; Ethanol: >100 mg/ml; PBS pH 7.2: >10 mg/ml | [form ]
A crystalline solid | [pka]
4.76±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
5-trans Prostaglandin F2α is an endogenous metabolite present in Blood that can be used for the research of Myocardial Infarction[1][2]. | [Definition]
ChEBI: 5-trans-PGF2alpha is a prostanoid. | [References]
[1] Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. DOI:10.1038/s41388-020-01395-9
[2] Strohmenger HU, et al. Concentrations of prolactin and prostaglandins during and after cardiopulmonary resuscitation. Crit Care Med. 1995 Aug;23(8):1347-55. DOI:10.1097/00003246-199508000-00007 |
|
|